Becton Dickinson Said to Mull Life Sciences Unit Separation (2)

Medical device maker Becton Dickinson & Co. is considering a potential separation of its life sciences segment, which could be valued at about $30 billion, according to people familiar with the matter.

Becton is working with advisers to study a possible separation of the division as it seeks to boost its stock price, the people said, asking not to be identified because the information is confidential.

Under the plan being considered, Becton would separate the biosciences and diagnostic solutions business while retaining its specimen management operations, the people said. Becton may announce the plans at the time of its Feb. ...